Coherus BioSciences, Inc. (CHRS) Social Stream
Coherus BioSciences Inc (CHRS) Price Targets From Analysts
Use the tables below to see what analysts covering Coherus BioSciences Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-17 | 7 | $30 | $19 | $25.428 | $13.23 | 92.2% |
| 2022-01-27 | 6 | $30 | $16 | $24.166 | $13.23 | 82.66% |
| 2022-02-18 | 6 | $30 | $16 | $23.666 | $13.23 | 78.88% |
| 2022-02-22 | 6 | $30 | $15 | $23.5 | $13.23 | 77.63% |
| 2022-03-07 | 6 | $30 | $15 | $22.666 | $13.23 | 71.32% |
| 2022-03-30 | 5 | $30 | $15 | $22.833 | $13.23 | 72.59% |
The Trend in the Analyst Price Target
Over the past 23 months, CHRS's average price target has gone down $8.28.
CHRS reports an average of 77.27% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-26 | 2 | 35 | 18 | 27.630 | 15.26 | 81.06% |
| 2021-07-24 | 9 | 36 | 16 | 26.500 | 13.07 | 102.75% |
| 2022-02-18 | 6 | 30 | 16 | 23.666 | 12.32 | 92.09% |
| 2022-03-07 | 6 | 30 | 15 | 22.666 | 11.61 | 95.23% |
| 2022-03-30 | 5 | 30 | 15 | 22.833 | 12.84 | 77.83% |
CHRS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.8 | 3 | 0 | 2 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
CHRS's average broker recommendation rating improved by 0.34 over the prior 151 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CHRS has a higher upside potential (average analyst target price relative to current price) than 669.08% of all US stocks.
- CHRS has a higher average analyst price target than 247.78% of all US stocks.
- Coherus BioSciences Inc's variance in analysts' estimates is lower than -541.89% of all US stocks.
- In the context of stocks in the small market cap category, Coherus BioSciences Inc's number of analysts covering the stock is greater than 689.96% of them.
Stocks similar to Coherus BioSciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CGEN, CGEM, and CDAK.
Make investment decisions regarding CHRS using the data that counts. Try POWR Ratings for free.